InvestorsHub Logo

NASDAQ2020

09/20/23 12:19 PM

#388064 RE: rdfdr1 #388059

Its initial testing was alongside of the reformulated SequestOx
In trials it surpassed SequestOx results. It was called Drug C in the trials.
Nasrat was excited on the next CC . On the down low due to competition.

GLTY